How to Buy Biomarin Pharmaceutical Stock
Biomarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions.
Biomarin Pharmaceutical stock last closed at $97.24, up 2.05% from the previous day, and has increased 26.12% in one year. It has overperformed other stocks in the Biotechnology industry by 0.52 percentage points. Biomarin Pharmaceutical stock is currently +37.48% from its 52-week low of $70.73, and -17.43% from its 52-week high of $117.77.
At the moment, there are 186.53M shares of BMRN outstanding. The market value of BMRN is $18.14B. In the last 24 hours, 1.43M BMRN shares were traded.
How to Buy Biomarin Pharmaceutical Stock
Not sure how to invest in Biomarin Pharmaceutical stock? Here's how.
- Choose where to buy Biomarin Pharmaceutical stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you determine where to buy Biomarin Pharmaceutical stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
- Put funds into your investment account: Select your payment method and add your details.
- Research Biomarin Pharmaceutical stock: The Biomarin Pharmaceutical ticker symbol is BMRN. Is Biomarin Pharmaceutical stock a good investment? Should you buy shares of BMRN? How do BMRN's underlying business fundamentals look? Do top analysts think Biomarin Pharmaceutical is a good buy? Why has BMRN's stock price moved recently? (Hint: Our stock research tools can help you decide if BMRN is a good stock to buy).
- Make your BMRN buy order: Decide if you will purchase BMRN shares at the current market price or use a limit order to buy BMRN shares at a given price.
- Get notifications regarding your BMRN investment: Create a watchlist to important notifications about your new investment in Biomarin Pharmaceutical shares.
Step 1: Choose where to buy Biomarin Pharmaceutical stock
You need an online brokerage account in order to access the NASDAQ market and buy BMRN stock.
Our recommended brokerage: eToro
We believe that eToro is the best stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to global markets: From Technology to Healthcare, New York to London — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro today.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal info so you are able to buy BMRN stock today.
How to Open a New Brokerage Account on eToro
- Click here to get started.
- Enter your personal details to open a new brokerage account.
- Send your information by pressing the "Create Account" button.
Step 3: Put funds into your investment account
Now that you've created your account on apps for stock market, your next step is to transfer the money for your investment:
Check out the walkthrough below if you need help transferring money into your investment account.
Step 4: Research Biomarin Pharmaceutical stock
Once you have decided on the best place to buy Biomarin Pharmaceutical stock, it's absolutely critical to research their stock prior to investing, so you actually understand the risk as well as the upside.
Biomarin Pharmaceutical Metrics
Biomarin Pharmaceutical Fundamentals
WallStreetZen was built to help part-time investors perform more accurate fundamental analysis quickly.
You can view all of the due diligence checks on BMRN's stock page.
Is BMRN stock undervalued or overvalued?
You can use many financial metrics, analyses, models, and charts to gauge BMRN's intrinsic value.
Using relative valuations ratios:
- BMRN may be overvalued based on its P/E ratio of 127.95x, relative to Biotechnology industry P/E ratio of 18.64x
- BMRN could be undervalued based on its P/B ratio of 3.94x, relative to Biotechnology industry P/B ratio of 4.98x
You can access more valuation analysis on BMRN's stock here.
BMRN Financial Health Overview
Pros:
- There are more short-term assets than short-term liabilities on the BMRN balance sheet.
- BMRN has a low debt to equity ratio of 0.39.
- BMRN profit margin has gone up from -3.5% to 6.8% in the past year.
- Total BMRN debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the BMRN balance sheet.
- BMRN earnings of $165.55M is not enough to cover its interest payments.
Cons:
- BMRN's operating cash flow of $175.90M allows it to safely service it's debt of $1.08B.
Is Biomarin Pharmaceutical stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 14 Wall Street analysts who give forecasts on BMRN, the consensus analyst rating on Biomarin Pharmaceutical is a Buy
Please keep in mind that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent BMRN Analyst Forecasts
William Pickering, a bottom 40% analyst from Bernstein initiates coverage on BMRN with a sell rating and announces their BMRN price target of $81.00, on Mar 21, 2023.
Kostas Biliouris, a bottom 11% analyst from BMO Capital maintains BMRN with a hold rating and lowers their BMRN price target from $107.00 to $102.00, on Mar 7, 2023.
Debjit Chattopadhyay, a bottom 17% analyst from Guggenheim reiterates BMRN with a strong buy rating and maintains their BMRN price target from $125.00 to $125.00, on Feb 28, 2023.
Paul Matteis, a bottom 10% analyst from Stifel Nicolaus maintains BMRN with a strong buy rating and raises their BMRN price target from $114.00 to $118.00, on Feb 28, 2023.
Andreas Argyrides, a bottom 15% analyst from Wedbush maintains BMRN with a hold rating and lowers their BMRN price target from $83.00 to $74.00, on Feb 28, 2023.
You can dive deeper into what analysts are forecasting on the Biomarin Pharmaceutical stock forecast page.
BMRN Trading Indicators
Is BMRN Making Money?
Last year, BMRN earnings were $141.56M. In the last 2 year, BMRN's earnings have grown by -59.87% per year. This was slower than the Biotechnology industry average of 64.65%.
Last year, BMRN revenue was $2.10B. Over the past 5 year, BMRN's revenue has increased by 9.8% per year. This was slower than the Biotechnology industry average of 41.53%.
Find out more about BMRN's earnings and revenue performance here.
Latest Insiders Trades at BMRN
Over the past 12 months, insiders at BMRN have sold more shares than they have bought.
Jeffrey Robert Ajer, EVP Chief Commercial Officer of BMRN, was the latest BMRN insider to sell. They sold $1,915,839.10 worth of BMRN shares on Mar 16, 2023.
Get more info about who owns BMRN stock here.
Can I rely on BMRN as an income stream?
No, Biomarin Pharmaceutical doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your BMRN buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a given dollar amount limit, use a limit order.
Hit the Open Trade button and your broker will execute the order.
If you need more info about investing in stocks on eToro, click the how to video below:
Step 6: Get notifications regarding your BMRN investment
Now that you own some BMRN stock, you'll want to stay up-to-date on your stock purchase.
Start a watchlist to see the latest developments about your BMRN stock.
BMRN Feed
How to Buy Stock in Biomarin Pharmaceutical
To reiterate, here are the 6 steps to buy Biomarin Pharmaceutical stock:
- Choose where to buy Biomarin Pharmaceutical stock
- Open your brokerage account
- Put funds into your investment account
- Research Biomarin Pharmaceutical stock
- Make your BMRN buy order
- Get notifications regarding your BMRN investment
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to watch your new investment in Biomarin Pharmaceutical, click the button below.
Related Articles
FAQ
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.